ICON Public (NASDAQ:ICLR) Issues FY24 Earnings Guidance

ICON Public (NASDAQ:ICLR) updated its FY24 earnings guidance on Wednesday. The company provided EPS guidance of $15.00-$15.20 for the period, compared to the consensus EPS estimate of $15.07. The company issued revenue guidance of $8.45-$8.55 billion, compared to the consensus revenue estimate of $8.64 billion.

Wall Street Analyst Weigh In

A number of research firms have recently commented on ICLR. The Goldman Sachs Group began coverage on shares of ICON Public in a report on Thursday, June 6th. They set a buy rating and a $370.00 price target on the stock. TD Cowen increased their price target on shares of ICON Public from $349.00 to $373.00 and gave the company a buy rating in a report on Friday, May 31st. William Blair reiterated an outperform rating on shares of ICON Public in a report on Friday, May 31st. Robert W. Baird increased their price target on shares of ICON Public from $367.00 to $376.00 and gave the company an outperform rating in a report on Monday, July 8th. Finally, Mizuho restated a buy rating and issued a $346.00 target price on shares of ICON Public in a report on Thursday, April 4th. One equities research analyst has rated the stock with a hold rating and ten have issued a buy rating to the company. Based on data from MarketBeat, ICON Public has a consensus rating of Moderate Buy and an average target price of $351.33.

ICON Public Stock Performance

Shares of ICLR stock traded down $18.67 during mid-day trading on Thursday, reaching $313.10. 1,550,372 shares of the company’s stock traded hands, compared to its average volume of 580,845. ICON Public has a 12 month low of $221.20 and a 12 month high of $347.72. The firm has a 50 day moving average price of $322.05 and a two-hundred day moving average price of $308.22. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.21 and a current ratio of 1.21. The firm has a market capitalization of $25.83 billion, a PE ratio of 38.14, a price-to-earnings-growth ratio of 1.48 and a beta of 1.23.

ICON Public (NASDAQ:ICLR) last issued its quarterly earnings data on Wednesday, July 24th. The medical research company reported $3.75 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.68 by $0.07. ICON Public had a net margin of 8.30% and a return on equity of 11.70%. The firm had revenue of $2.10 billion during the quarter, compared to the consensus estimate of $2.14 billion. During the same quarter in the previous year, the firm posted $2.96 EPS. The company’s revenue for the quarter was up 4.1% compared to the same quarter last year. On average, research analysts forecast that ICON Public will post 14.54 EPS for the current year.

ICON Public Company Profile

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.